Rasio rega marang bathi ChromaDex (NAGE)

Minimal geopolitical influence creates a stable backdrop for Chromadex Corp (NAGE). Resilience is driven by B2B supplies of the Niagen component, which guarantee regular orders and high margins. The company's monthly P/E dynamics visualize the value of future earnings, where the value of 16.40 reflects the metric's balance. Innovations in cellular regeneration and DNA repair to slow aging establish the foundation for growth.

ChromaDex Corp (NAGE) - Pangali P/E saka 20.03.2025 nganti 12.11.2026

Rincian analitis perusahaan Chromadex Corp

- rega lan prakiraan konsensus rega:

Rega saham Niagen|NAGE - Bagan rega target

- rincian kapitalisasi pasar:

Nilai pasar ChromaDex Corp.|NAGE - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- informasi kapitalisasi buku:

Nilai Akuntansi Saham ChromaDex|NAGE - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku niagenbioscience.com|NAGE - Aset Agregat Perusahaan

- statistik kawajiban utang lan likuiditas:

Rasio Utang marang Ekuitas Chromadex Corp|NAGE - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal niagenbioscience.com|NAGE - Gunggung utang perusahaan|Utang marang modal buku ChromaDex Corp.|NAGE - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan ChromaDex|Rasio cepet niagenbioscience.com

- indikator bathi lan kelipatan valuasi:

NAGE - Bathi resik perusahaan|Bathi mangsa ngarep Chromadex Corp|NAGE - Pangali P/E|Rasio prakiraan rega marang bathi ChromaDex Corp|NAGE - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan ChromaDex Corp.|NAGE - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan ChromaDex|NAGE - Bathi saben saham sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan niagenbioscience.com|NAGE - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Chromadex Corp

Analisis umum perusahaan:ChromaDex Corp., NAGE

Investors determine the potential of Chromadex Corp (NAGE) through the price-to-earnings ratio, which measures the cost of one dollar of current earnings and reflects market expectations for future growth rates. By analyzing the company's calculated P/E, the strategist assesses whether the premium for the expansion of biohacking products in retail is justified, separating the business's fundamental value from speculative price inflation.

Analisis perusahaan pesaing